Inventor · disambiguated record
Rubina G. Parmar
Also filed as: PARMAR RUBINA · PARMAR RUBINA G · PARMAR RUBINA GIARE
25 granted patents·14 pending applications·111 citations·filing 2009–2024
95Inventor score
Files withALNYLAM PHARMACEUTICALS INC18INTELLIA THERAPEUTICS INC7SIRNA THERAPEUTICS INC6MERCK SHARP & DOHME4BARRETT STEPHANIE E1
Top patents by PatentIndex Score
39 records- 0198US10612024B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Apr 7, 2020·15 cites·35 claims
- 0298US10612027B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Apr 7, 2020·26 cites·25 claims
- 0398US10233448B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Mar 19, 2019·37 cites·40 claims
- 0496US11401517B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Aug 2, 2022·6 cites·24 claims
- 0594US12385044B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Aug 12, 2025·0 cites·30 claims
- 0693US12385043B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Aug 12, 2025·0 cites·35 claims
- 0788US12168767B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Dec 17, 2024·0 cites·25 claims
- 0888US11117917B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 0988US10532068B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2018·Granted Jan 14, 2020·3 cites·18 claims
- 1086US12378553B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Aug 5, 2025·0 cites·43 claims
- 1185US11549109B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Jan 10, 2023·0 cites·30 claims
- 1284US10221205B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·3 cites·20 claims
- 1384US9655976B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted May 23, 2017·6 cites·35 claims
- 1483US12005074B2Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2023·Granted Jun 11, 2024·0 cites·28 claims
- 1583US8987377B2Poly(amide) polymers for the delivery of oligonucleotidesBARRETT STEPHANIE E·Filed 2011·Granted Mar 24, 2015·7 cites·18 claims
- 1683US2024358738A1Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1782US11427822B2Modified double-stranded RNA agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Aug 30, 2022·0 cites·24 claims
- 1882US10010562B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Jul 3, 2018·3 cites·20 claims
- 1981US2022002727A1Modified double-stranded rna agentsALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2077US12304925B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2021·Granted May 20, 2025·0 cites·20 claims
- 2177US10933081B2Myostatin iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Mar 2, 2021·1 cites·20 claims
- 2276US2025163417A1Compositions and methods for improving strand biasedALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2373US8901101B2Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotidesBUSUEK MARINA·Filed 2011·Granted Dec 2, 2014·2 cites·9 claims
- 2470US12397013B2Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Aug 26, 2025·0 cites·66 claims
- 2567US9840531B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·0 cites·21 claims
- 2665US12173287B2Compositions and methods for improving strand biasedALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Dec 24, 2024·0 cites·20 claims
- 2765US2024299583A1Modified Guide RNAs for Gene EditingINTELLIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2864US2024150761A1Modified Guide RNAs Comprising an Internal Linker for Gene EditingINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2963US9402914B2Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2014·Granted Aug 2, 2016·0 cites·17 claims
- 3061US2011224447A1Novel Lipid Nanoparticles and Novel Components for Delivery of Nucleic AcidsBOWMAN KEITH A·Filed 2009·Application pending·0 cites
- 3155US2022307024A1Delivery of oligonucleotides to the striatumALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3254US2025090471A1Lipid nanoparticle compositionsINTELLIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3353US2021087568A1Modified Guide RNAs for Gene EditingINTELLIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3451US2024200106A1Lipid nanoparticles compositionsINTELLIA THRAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3550US2024300977A1Inhibitors of dna-dependent protein kinase and compositions and uses thereofINTELLIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3647US10239957B2Peptide containing conjugates for dual molecular delivery of oligonucleotidesMERCK SHARP & DOHME·Filed 2014·Granted Mar 26, 2019·0 cites·1 claims
- 3744US2013005797A1Endosomolytic poly(amidoamine) disulfide polymers for the delivery of oligonucleotidesMERCK SHARP & DOHME·Filed 2011·Application pending·0 cites
- 3842US2022402862A1Ionizable amine lipids and lipid nanoparticlesINTELLIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3942US2022009878A1Ionizable amine lipidsINTELLIA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rubina G. Parmar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →